CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

Regions
Topics
Saved views:
Save your current filters to revisit or share.
32 stories
🇲🇽 El Financiero (ES)
National & Local

Mazdutide, the 'miracle' injection to lose up to 15% of weight created by China

A new obesity medication, Mazdutide, developed by China’s Innovent Biologics and Eli Lilly, has shown significant weight loss results and is on track for approval in China.

Feb 27 • 03:11 UTC
🇲🇽 El Financiero (ES)
National & Local

Lilly Téllez accuses Sheinbaum of acting against ‘El Mencho’ under US pressure: ‘We wanted him speaking’

Senator Lilly Téllez accused President Claudia Sheinbaum of acting against drug lord 'El Mencho' due to alleged pressure from the United States.

Feb 25 • 20:08 UTC
🇲🇽 El Financiero (ES)
National & Local

Adán Augusto, Noroña and Lilly Téllez: They would not be in the Senate with Sheinbaum's electoral reform

The electoral reform proposal by Claudia Sheinbaum aims to eliminate proportional representation lists in the Senate, potentially displacing lawmakers like Adán Augusto and Lilly Téllez.

Feb 25 • 19:13 UTC
🇧🇷 Folha (PT)
National & Local

Losing too much weight with weight-loss pens worries doctors

Recent findings raise concerns among doctors regarding weight-loss medications that may cause excessive weight loss.

Feb 24 • 10:00 UTC
🇧🇷 Folha (PT)
National & Local

Novo Nordisk's shares plummet more than 16% after results of new drug

Novo Nordisk's shares sharply declined following disappointing clinical trial results of its new weight-loss drug, CagriSema, which underperformed compared to a competitor's product.

Feb 23 • 19:00 UTC
🇬🇷 Naftemporiki
National & Local

Novo Nordisk: 15% Drop in Stock - Why the Clinical Trial of CagriSema Was Disappointing

Novo Nordisk's stock plummeted 15% after its new drug CagriSema failed to meet key weight-loss targets in a clinical trial compared to Eli Lilly's tirzepatide.

Feb 23 • 11:50 UTC
🇪🇸 El País
National & Local

Novo Nordisk sinks again on the stock market after failing trials for its new obesity drug

Novo Nordisk's shares dropped significantly after the company reported failures in trials for its experimental obesity drug, CagriSema.

Feb 23 • 11:08 UTC
🇦🇷 La Nacion (ES)
National & Local

What if weight loss medications work too well?

There are emerging concerns regarding weight loss medications, which, while effective, may lead to unhealthy weight loss and eating disorders.

Feb 21 • 10:00 UTC
🇦🇷 Clarin (ES)
National & Local

Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them

A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.

Feb 20 • 19:38 UTC
🇮🇹 Il Giornale
Crime & Justice

Lilly Case, back and forth with the widower and the last words of Sterpin

The death of Claudio Sterpin has triggered public scrutiny regarding the ongoing investigation into Liliana Resinovich's disappearance and subsequent death in Trieste.

Feb 19 • 13:14 UTC
🇬🇷 Naftemporiki
National & Local

New concerns about weight loss drugs: What happens if they work... too well?

Recent trials involving the weight loss drug retatrutide have raised concerns after participants reported significant weight loss, but also higher than normal dropout rates due to side effects.

Feb 18 • 21:20 UTC
🇦🇷 Clarin (ES)
National & Local

New concerns about weight loss medications: What happens if they work too well?

Recent trials of a weight loss drug called retatrutide show significant weight loss, raising concerns among researchers about the potential for excessive weight loss and related side effects.

Feb 18 • 20:43 UTC
🇩🇪 FAZ
National & Local

New Advisor Blaudszun: Allegations of Collusion Against Manuela Schwesig

Manuela Schwesig has appointed political influencer Lilly Blaudszun for her election campaign, amidst ongoing criticism regarding potential conflicts of interest related to Blaudszun's work with a government-funded agency.

Feb 16 • 15:38 UTC
🇫🇷 France24
National & Local

A cultural stroll through Paris with actor Michel Boujenah and Lilly Wood & the Prick

The article features a cultural exploration in Paris with actor Michel Boujenah and the band Lilly Wood & the Prick, highlighting Boujenah's current theatrical performance and the band's new album release.

Feb 16 • 12:49 UTC
🇪🇸 El País
National & Local

Lilly Reich (and not Mies) in the Barcelona Pavilion: a masterpiece finds its author

The article discusses how the contributions of architect Lilly Reich to the iconic Barcelona Pavilion, designed for the 1929 International Exposition, have been historically overlooked in favor of her male counterpart Ludwig Mies van der Rohe.

Feb 16 • 04:45 UTC
🇪🇸 El Mundo
National & Local

Lilly bets on Spain to manufacture obesity pills: 'A new plant will allow us to quadruple the amount produced here'

Lilly, the American multinational, is investing 153 million euros in expanding its production plant in Alcobendas, Spain, to significantly increase its capacity for producing obesity treatment pills.

Feb 15 • 23:00 UTC
🇰🇷 Hankyoreh (KR)
Crime & Justice

Impersonating Mountzaro: Illegal Sale of Obesity Treatment Thrives on SNS

There has been a surge in illegal sales of unauthorized diet drugs impersonating Korean Lilly, particularly through social media, amidst growing interest in obesity treatments.

Feb 6 • 08:38 UTC
🇲🇽 El Financiero (ES)
National & Local

Lilly Téllez calls for transparency in usage of aesthetics and accuses Morena of leaking information about the space

Senator Lilly Téllez from the National Action Party called for transparency regarding the use of aesthetics in the Senate, alleging leaks from Morena members.

Feb 6 • 02:20 UTC
🇩🇪 Die Welt
National & Local

Eli Lilly or Novo Nordisk? The stock market has mercilessly decided

The market for weight-loss injections is expanding, but investors have decisively favored one pharmaceutical giant over the other.

Feb 5 • 16:25 UTC
🇦🇷 Clarin (ES)
Life & Tech

How the drugs that will revolutionize obesity treatment work

Semaglutide by Novo Nordisk is the first drug approved for obesity treatment that achieves weight loss comparable to bariatric surgery, while Eli Lilly's tirzepatide is expected to gain approval soon after showing efficacy and safety in clinical trials.

Feb 5 • 10:01 UTC
🇮🇸 Visir
National & Local

"I did not have the imagination to see this for myself"

Jakob Bjarnar and Lillý Valgerður Pétursdóttir discuss the surprising news that Bjarni Benediktsson has become the director of the Business Association, which will influence wage negotiations.

Jan 26 • 14:09 UTC
🇶🇦 Al Jazeera
Life & Tech

The US FDA requests the removal of the 'suicidal thoughts' warning from weight loss drugs

The FDA has requested pharmaceutical companies to remove warnings about potential suicidal thoughts from labels of common weight-loss medications, including Novo Nordisk's 'Wegovy' and Eli Lilly's 'Zyban', following a comprehensive review that found no link to such thoughts.

Jan 14 • 12:47 UTC
🇪🇸 El País
Life & Tech

Novo Nordisk achieves a pyrrhic victory with Wegovy pills

Novo Nordisk's new oral obesity drug Wegovy offers only a minor advantage over Eli Lilly in the ongoing pharmaceutical battle for obesity treatments.

Jan 14 • 04:40 UTC
🇭🇷 Večernji List
Life & Tech

Famous actress revealed a severe diagnosis: 'I have brain damage, I function at reduced capacity'

Canadian actress Evangeline Lilly has disclosed her brain damage diagnosis resulting from a serious injury, as shared in an emotional Instagram video.

Jan 8 • 07:00 UTC
🇩🇪 Die Welt
Life & Tech

"My brain only works to a limited extent" – "Lost" star makes serious illness public

Evangeline Lilly, known for her roles in "Lost" and the Marvel universe, reveals she is suffering from serious health issues following a severe injury in 2025.

Jan 5 • 11:39 UTC
🇬🇷 Proto Thema
Life & Tech

Evangeline Lilly revealed that she suffered brain damage after an accident: Almost every area of my brain is underfunctioning

Evangeline Lilly disclosed that she incurred brain damage from an accident, resulting in reduced functionality in nearly every area of her brain.

Jan 5 • 10:12 UTC
🇬🇷 Proto Thema
Life & Tech

Lost star diagnosed with brain injury months after fall on beach - Watch video

Evangeline Lilly, known for her role in Lost, revealed she was diagnosed with a traumatic brain injury following a serious accident on a beach in Hawaii.

Jan 5 • 10:00 UTC
🇪🇸 El País
Life & Tech

Evangeline Lilly, actress of 'Lost', reveals that she suffers brain damage following a traumatic brain injury

Evangeline Lilly has disclosed on her Instagram that she is experiencing brain damage as a result of a traumatic brain injury from a fall she had in May 2025.

Jan 5 • 09:36 UTC
🇬🇧 Guardian
Life & Tech

Evangeline Lilly reveals she has brain damage after hitting her head in fall

Evangeline Lilly disclosed that she has sustained brain damage following a concussion from a fall where she hit her head on a boulder.

Jan 4 • 23:29 UTC
🇺🇸 Fox News
Life & Tech

Evangeline Lilly confirms she sustained brain damage from traumatic injury last year

Evangeline Lilly reports that she has sustained brain damage following a head injury from a fall in May 2025, highlighting concerns about her cognitive health.

Jan 4 • 17:04 UTC
🇪🇸 ABC
Life & Tech

The actress from 'Lost' Evangeline Lilly reveals that she has brain damage after suffering a fall on the beach

Evangeline Lilly has disclosed that she is experiencing brain damage as a result of a fall at a beach in Hawaii, expressing concerns about potential cognitive decline.

Jan 4 • 16:31 UTC
🇬🇧 Mirror
Life & Tech

Lost and Marvel star Evangeline Lilly suffering 'brain damage' after horror accident

Evangeline Lilly has revealed a diagnosis of brain damage following a serious accident that left her hospitalized and with decreased brain function.

Jan 3 • 17:55 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.